Rezultati pretraživanja
  1. prije 3 sata

    Novo Nordisk doesn't seem to be especially fazed by the development of hemophilia GTx.

    1 reply 1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  2. prije 3 sata

    Some interesting slides from recent corporate presentation. I hope they get the AMT-130 trial started soon. This is way overdue.

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
  3. prije 4 sata

    Evaluation of a Blood Coagulation Factor IX Variant that Functions Independently of Factor VIII as an Alternative Treatment for

    1 korisnik označava da mu se sviđa
  4. prije 4 sata
    Odgovor korisniku/ci

    looking great in HemB Is that “Average PEAK” factor levels (for high dose) being graphed in HemA slide? Because I’m pretty sure chart looks like this after the peak. SB525 looking like an extreme outlier for HemA... 👀👇

    3 korisnika označavaju da im se sviđa
  5. 4. velj

    watching Good Morning to everyone but Etrade

    2 korisnika označavaju da im se sviđa
  6. 4. velj

    Programs in Development for Disease

    1 reply 7 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  7. 4. velj

    If this can regain $61.50, then it will see $64.50 shortly after. Bullish engulfing today.

  8. 3. velj

    Insider Selling: Uniqure NV CEO Sells 23,583 Shares of Stock

  9. 3. velj

    Expecting huge recovery on oversold beaten down best in class and most promising Will only get higher from here if coronavirus stays relatively contained in US and outside China. and small plays in , data expected

    1 korisnik označava da mu se sviđa
  10. 2. velj

    Deventer Sander Van Sells 2,227 Shares of Uniqure NV Stock

  11. 1. velj

    Only M&A's Can Save Us Now; and the Near- Term Caucus Calendar Are Not Particularly Conducive

    16 proslijeđenih tweetova 35 korisnika označava da im se sviđa
  12. 31. sij

    Added small 314’s 56.08 18.4

    1 reply 2 proslijeđena tweeta 13 korisnika označava da im se sviđa
  13. 31. sij

    1 reply 2 korisnika označavaju da im se sviđa
  14. 30. sij
    Odgovor korisnicima

    Unbelievable. This was a planned sale, too. Matt did the same obscene selling amount early last year and only went 8,000 share autopilot after a few months into the year.

    2 korisnika označavaju da im se sviđa
  15. 30. sij

    what’s going on with these sales by Matt and Dr. Gut? These don’t look like the normal pre-arranged sales.

    1 reply 1 korisnik označava da mu se sviđa
  16. 29. sij

    : New Insider Filing on CEO, CFO, Managing Director MATTHEW C KAPUSTA:

  17. 29. sij

    We should sue all of those insider management fools that most of you people out there love. They are basically selling on insider information but now they’re going after the big bucks. Multiple seven figures plus!The more they screw up the more they sell.

    1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.